nivolumab,ipilimumab
bms
['nivolumab', 'ipilimumab', 'nivo']
#asco22 | poster 114 | mon 1:15pm cdt
a retrospective study of ipilimumab plus nivolumab in anti pd-l1/pd-1-refractory merkel cell carcinoma.
presenter: sophia z. shalhout, phd ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.